{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:55:04Z","timestamp":1780487704797,"version":"3.54.1"},"reference-count":42,"publisher":"Consortium of Multiple Sclerosis Centers","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11,1]]},"abstract":"<jats:p>Background: Anxiety is prevalent in people with multiple sclerosis (MS). Screening measures are used to identify symptoms of anxiety, but the optimal measure to screen for anxiety disorders in MS has not been established.<\/jats:p><jats:p>Methods: We searched the MEDLINE, Embase, PsycINFO, PsycARTICLES Full Text, Cumulative Index to Nursing and Allied Health Literature, Web of Science, and Scopus databases from database inception until August 7, 2015. Two independent reviewers screened abstracts and full-text reports for study inclusion, extracted data, and assessed risk of bias. We included studies that evaluated the criterion validity of anxiety screening tools when measuring anxiety in individuals with well-documented MS, as measured by sensitivity, specificity, and positive and negative predictive values.<\/jats:p><jats:p>Results: Of the 3181 abstracts screened, 18 articles were reviewed in full text, of which 4 met the inclusion criteria. The criterion validity of three screening tools was assessed: the Hospital Anxiety and Depression Scale\u2013Anxiety (HADS-A), Beck Anxiety Inventory (BAI), and 7-item Generalized Anxiety Disorder Scale (GAD-7). The HADS-A was validated against the Structured Clinical Interview for DSM-IV, the Schedules for Clinical Assessment in Neuropsychiatry (SCAN) interview, and the BAI. The BAI was validated against the SCAN, and the GAD-7 was validated against the HADS-A. The HADS-A had higher measures of sensitivity and specificity than did the BAI and the GAD-7.<\/jats:p><jats:p>Conclusions: Based on this small sample, the HADS-A shows promise as an applicable measure for people with MS. Screening scales used to identify anxiety in MS must be validated against appropriate reference standards.<\/jats:p>","DOI":"10.7224\/1537-2073.2016-004","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T14:17:55Z","timestamp":1465309075000},"page":"273-281","source":"Crossref","is-referenced-by-count":36,"title":["Screening Tools for Anxiety in People with Multiple Sclerosis"],"prefix":"10.7224","volume":"18","author":[{"given":"Brittany","family":"Litster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten M.","family":"Fiest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott B.","family":"Patten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Fisk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"Graff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Bolton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitender","family":"Sareen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Marriott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay I.","family":"Berrigan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles N.","family":"Bernstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Zarychanski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Singer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Hitchon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A.","family":"Peschken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Marrie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the CIHR Team \u201cDefining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease\u201d","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4242","reference":[{"key":"2020060301034409400_i1537-2073-18-6-273-b1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/da.20072","article-title":"The relationship between anxiety disorders and physical disorders in the U.S. National Comorbidity Survey","volume":"21","author":"Sareen","year":"2005","journal-title":"Depress Anxiety"},{"key":"2020060301034409400_i1537-2073-18-6-273-b2","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1001\/archinte.166.19.2109","article-title":"Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions","volume":"166","author":"Sareen","year":"2006","journal-title":"Arch Intern Med"},{"key":"2020060301034409400_i1537-2073-18-6-273-b3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/1352458514564487","article-title":"The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult Scler"},{"key":"2020060301034409400_i1537-2073-18-6-273-b4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13651500701330825","article-title":"Mood and anxiety disorders in patients with multiple sclerosis","volume":"12","author":"Uguz","year":"2008","journal-title":"Int J Psychiatry Clin Pract"},{"key":"2020060301034409400_i1537-2073-18-6-273-b5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1352458506071161","article-title":"Anxiety disorders and their clinical correlates in multiple sclerosis patients","volume":"13","author":"Korostil","year":"2007","journal-title":"Mult Scler"},{"key":"2020060301034409400_i1537-2073-18-6-273-b6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1468-1331.2007.02041.x","article-title":"Depression and anxiety amongst multiple sclerosis patients","volume":"15","author":"Beiske","year":"2008","journal-title":"Eur J Neurol"},{"key":"2020060301034409400_i1537-2073-18-6-273-b7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/135245859900500504","article-title":"The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis","volume":"5","author":"Feinstein","year":"1999","journal-title":"Mult Scler"},{"key":"2020060301034409400_i1537-2073-18-6-273-b8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10865-010-9247-y","article-title":"Treatment adherence in multiple sclerosis: association with emotional status, personality, and cognition","volume":"33","author":"Bruce","year":"2010","journal-title":"J Behav Med"},{"key":"2020060301034409400_i1537-2073-18-6-273-b9","first-page":"421","article-title":"Implications of nonadherence for economic evaluation and health policy","author":"van Houtven","year":"2005","journal-title":"Patient Treatment Adherence: Concepts, Interventions, and Measurement"},{"key":"2020060301034409400_i1537-2073-18-6-273-b10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1037\/a0020492","article-title":"Comorbid anxiety disorders and treatment of depression in people with multiple sclerosis","volume":"55","author":"Burns","year":"2010","journal-title":"Rehabil Psychol"},{"key":"2020060301034409400_i1537-2073-18-6-273-b11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","article-title":"An inventory for measuring clinical anxiety: psychometric properties","volume":"56","author":"Beck","year":"1988","journal-title":"J Consult Clin Psychol"},{"key":"2020060301034409400_i1537-2073-18-6-273-b12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1023\/A:1025573315492","article-title":"Identification of Beck Depression Inventory items related to multiple sclerosis","volume":"20","author":"Mohr","year":"1997","journal-title":"J Behav Med"},{"key":"2020060301034409400_i1537-2073-18-6-273-b13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3810\/pgm.2012.09.2595","article-title":"Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis","volume":"124","author":"Sjonnesen","year":"2012","journal-title":"Postgrad Med"},{"key":"2020060301034409400_i1537-2073-18-6-273-b14","unstructured":"Litster B , FiestKM, MarrieRA. Systematic Review of Screening Tools for Anxiety in Persons With Multiple Sclerosis. PROSPERO; 2015."},{"key":"2020060301034409400_i1537-2073-18-6-273-b15","doi-asserted-by":"crossref","first-page":"889","DOI":"10.7326\/0003-4819-149-12-200812160-00008","article-title":"Systematic reviews of diagnostic test accuracy","volume":"149","author":"Leeflang","year":"2008","journal-title":"Ann Intern Med"},{"key":"2020060301034409400_i1537-2073-18-6-273-b16","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"2020060301034409400_i1537-2073-18-6-273-b17","unstructured":"EPPI-Reviewer 4 [computer program]. London, UK: Social Science Research Unit, Institute of Education; 2010."},{"key":"2020060301034409400_i1537-2073-18-6-273-b18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"2020060301034409400_i1537-2073-18-6-273-b19","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1177\/1352458509347150","article-title":"Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients","volume":"15","author":"Honarmand","year":"2009","journal-title":"Mult Scler"},{"key":"2020060301034409400_i1537-2073-18-6-273-b20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7224\/1537-2073.2014-008","article-title":"The 7-item generalized anxiety disorder scale as a tool for measuring generalized anxiety in multiple sclerosis","volume":"17","author":"Terrill","year":"2015","journal-title":"Int J MS Care"},{"key":"2020060301034409400_i1537-2073-18-6-273-b21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7224\/1537-2073.2013-013","article-title":"Validation of mood measures for people with multiple sclerosis","volume":"16","author":"Watson","year":"2014","journal-title":"Int J MS Care"},{"key":"2020060301034409400_i1537-2073-18-6-273-b22","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1191\/0269215501cr427oa","article-title":"Assessment of emotional problems in people with multiple sclerosis","volume":"15","author":"Nicholl","year":"2001","journal-title":"Clin Rehabil"},{"key":"2020060301034409400_i1537-2073-18-6-273-b23","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Publishing; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"2020060301034409400_i1537-2073-18-6-273-b24","doi-asserted-by":"crossref","first-page":"601","DOI":"10.4088\/JCP.13m08961","article-title":"A clinically useful self-report measure of the DSM-5 anxious distress specifier for major depressive disorder","volume":"75","author":"Zimmerman","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"2020060301034409400_i1537-2073-18-6-273-b25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0959-8049(05)80015-2","article-title":"Screening for anxiety and depression in cancer patients: the effects of disease and treatment","volume":"30A","author":"Ibbotson","year":"1994","journal-title":"Eur J Cancer"},{"key":"2020060301034409400_i1537-2073-18-6-273-b26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1192\/bjp.156.1.79","article-title":"Screening for adjustment disorders and major depressive disorders in cancer in-patients","volume":"156","author":"Razavi","year":"1990","journal-title":"Br J Psychiatry"},{"key":"2020060301034409400_i1537-2073-18-6-273-b27","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/0959-8049(92)90025-W","article-title":"Screening for psychiatric disorders in a lymphoma out-patient population","volume":"28A","author":"Razavi","year":"1992","journal-title":"Eur J Cancer"},{"key":"2020060301034409400_i1537-2073-18-6-273-b28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/13651509909024758","article-title":"Screening for adjustment disorders and major depression in otolaryngology patients using the Hospital Anxiety and Depression Scale","volume":"3","author":"Hosaka","year":"1999","journal-title":"Int J Psychiatry Clin Pract"},{"key":"2020060301034409400_i1537-2073-18-6-273-b29","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/bjc.1995.538","article-title":"Can mood disorder in women with breast cancer be identified preoperatively?","volume":"72","author":"Ramirez","year":"1995","journal-title":"Br J Cancer"},{"key":"2020060301034409400_i1537-2073-18-6-273-b30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1192\/bjp.165.5.669","article-title":"A validity study of the Hospital Anxiety and Depression Scale in general hospital units and a community sample in Nigeria","volume":"165","author":"Abiodun","year":"1994","journal-title":"Br J Psychiatry"},{"key":"2020060301034409400_i1537-2073-18-6-273-b31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-0447.1995.tb09778.x","article-title":"Screening instruments for depression and anxiety following stroke: experience in the Perth community stroke study","volume":"91","author":"Johnson","year":"1995","journal-title":"Acta Psychiatr Scand"},{"key":"2020060301034409400_i1537-2073-18-6-273-b32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MLR.0b013e318160d093","article-title":"Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population","volume":"46","author":"Lowe","year":"2008","journal-title":"Med Care"},{"key":"2020060301034409400_i1537-2073-18-6-273-b33","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/cpp.1802","article-title":"Validity of the Generalized Anxiety Disorder-7 scale in an acute psychiatric sample","volume":"20","author":"Kertz","year":"2013","journal-title":"Clin Psychol Psychother"},{"key":"2020060301034409400_i1537-2073-18-6-273-b34","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jagp.2013.01.076","article-title":"Assessing generalized anxiety disorder in elderly people using the GAD-7 and GAD-2 scales: results of a validation study","volume":"22","author":"Wild","year":"2014","journal-title":"Am J Geriatr Psychiatry"},{"key":"2020060301034409400_i1537-2073-18-6-273-b35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.msard.2015.10.004","article-title":"Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis","volume":"5","author":"Fiest","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"2020060301034409400_i1537-2073-18-6-273-b36","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/archpsyc.60.11.1117","article-title":"Mild disorders should not be eliminated from the DSM-V","volume":"60","author":"Kessler","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"2020060301034409400_i1537-2073-18-6-273-b37","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1017\/S0033291702006074","article-title":"Short screening scales to monitor population prevalences and trends in non-specific psychological distress","volume":"32","author":"Kessler","year":"2002","journal-title":"Psychol Med"},{"key":"2020060301034409400_i1537-2073-18-6-273-b38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1017\/S0033291702006700","article-title":"The performance of the K6 and K10 screening scales for psychological distress in the Australian National Survey of Mental Health and Well-Being","volume":"33","author":"Furukawa","year":"2003","journal-title":"Psychol Med"},{"key":"2020060301034409400_i1537-2073-18-6-273-b39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/da.20182","article-title":"Development and validation of an Overall Anxiety Severity and Impairment Scale (OASIS)","volume":"23","author":"Norman","year":"2006","journal-title":"Depress Anxiety"},{"key":"2020060301034409400_i1537-2073-18-6-273-b40","first-page":"127","article-title":"A Dutch version of the Overall Anxiety Severity and Impairment Scale (OASIS): psychometric properties and validation","volume":"172C","author":"Hermans","year":"2014","journal-title":"J Affect Disord"},{"key":"2020060301034409400_i1537-2073-18-6-273-b41","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1212\/WNL.0000000000002564","article-title":"Health-related quality of life in multiple sclerosis: direct and indirect effects of comorbidity","volume":"86","author":"Berrigan","year":"2016","journal-title":"Neurology"},{"key":"2020060301034409400_i1537-2073-18-6-273-b42","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1212\/WNL.0000000000002543","article-title":"Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis","volume":"86","author":"Zhang","year":"2016","journal-title":"Neurology"}],"container-title":["International Journal of MS Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/ijmsc\/article-pdf\/18\/6\/273\/2092279\/1537-2073_2016-004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/ijmsc\/article-pdf\/18\/6\/273\/2092279\/1537-2073_2016-004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T21:11:51Z","timestamp":1752786711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijmsc.org\/view\/screening-tools-for-anxiety-in-people-with-multiple-sclerosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,1]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11,1]]}},"URL":"https:\/\/doi.org\/10.7224\/1537-2073.2016-004","relation":{},"ISSN":["1537-2073"],"issn-type":[{"value":"1537-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11,1]]}}}